Vaccination against chickenpox is estimated to significantly reduce varicella cases and deaths in both children and adults and would be cost-effective, per a modelling study in Denmark, informing policymakers around routine immunization (IMAGE)

PLOS

Vaccination against chickenpox is estimated to significantly reduce varicella cases and deaths in both children and adults and would be cost-effective, per a modelling study in Denmark, informing policymakers around routine immunization

Caption

A) Total and B) breakthrough varicella incidence over time, by vaccination strategy. Panel A: Total varicella incidence, including natural and breakthrough cases, over 50 years after the start of universal childhood varicella vaccination. Panel B: Breakthrough varicella incidence over 50 years. In both panels, varicella incidence with strategies E and F were the same as for strategies C and D, respectively. Strategy A: V-MSD (12 months) + V-MSD (15 months); Strategy B: V-GSK (12 months) + V-GSK (15 months); Strategy C: V-MSD (15 months) + V-MSD (48 months); Strategy D: V-GSK (15 months) + V-GSK (48 months); Strategy E: V-MSD (15 months) + MMRV-MSD (48 months); Strategy F: V-GSK (15 months) + MMRV-GSK (48 months).

Credit

Burgess et al., 2023, PLOS Global Public Health, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/)

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.